Scientists explored a class of adjuvant that harnessed mucosal-associated invariant T (MAIT) cells, and showed evidence that intranasal immunization of MAIT cell agonists co-administered with protein induced protective humoral immunity and immunoglobulin A production.
[Cell Reports]